Ning Guang, an academician of the Chinese Academy of Engineering and Dean of Ruijin Hospital, made the main report of “The Development of the Biomedical Industry” at the meeting of the clinical resources.Academician Ning Guang said that the biomedical industry is a national strategic emerging industry. In recent years, due to policy support and technological progress, my country’s biomedical innovation capabilities have entered the second echelon from the third echelon in the world.In the speech, Researcher Wu Jiarui, director of the National Protection Science Research (Shanghai) facilities, used the title of “big data -driven life and health science” to reveal how big data technology empower life science research and promote the development of precision medical care.Zhu Yanwen, the Medical Review Department of the Pharmaceutical Review and Inspection of the Pharmaceutical Review and Inspection, deeply analyzed the in -depth analysis of “accelerating the reform of drug review and promoting the innovation of biomedical innovation in my country”, exploring how systemic innovation can catalyze high -quality drugs to the market quickly, and stimulate industrial innovation vitality.Researcher Yin Junping, Dean of the Zhangjiang Institute of Mathematics, explained the key role of mathematics in cracking life passwords and helping to develop biomedical research and development.Professor Zhang Yuanyuan of the School of Medicine of the University of Electronic Science and Technology discusses how to cultivate compound talents that meet future medical needs and promote deep integration of medical education, scientific research and industry.The forum has built a high -level ideological exchange and cooperation platform, further united the city’s innovation consensus, and injects strong momentum into the exploration of my country’s life science and the innovation and development of the biomedical industry.